Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. : Preparing a Clinical Outcomes Assessment Set for Nephrotic Syndrome
This registration includes concept elicitation, analysis and creation of complementary survey measures focused on edema/fluid overload of nephrotic syndrome. The measures to be developed include an Observer Reported Outcome (ObsRO) and Patient Reported Outcome (PRO). The ObsRO and PRO substudies are Institutional Review Board (IRB) approved at release.The researcher's goal is to produce core outcome sets of patient-rated and observer reported Fluid Overload (edema) measures that can be applied across the fluid overload severity continuum, fit to help drug development in this area..
Medienart: |
Klinische Studie |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
ClinicalTrials.gov - (2023) vom: 13. Sept. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: August 17, 2022, Last downloaded: ClinicalTrials.gov processed this data on September 20, 2023, Last updated: September 20, 2023 |
---|
Study ID: |
NCT05505500 |
---|---|
Veröffentlichungen zur Studie: |
|
fisyears: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
CTG00862125X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | CTG00862125X | ||
003 | DE-627 | ||
005 | 20230920011429.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220824s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)CTG00862125X | ||
035 | |a (UBBS_Klinische_Studien)NCT05505500 | ||
035 | |a (UBBS_Klinische_Studien)HUM00208148 | ||
035 | |a (UBBS_Klinische_Studien)5UG3FD007308-02 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. |b Preparing a Clinical Outcomes Assessment Set for Nephrotic Syndrome |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: August 17, 2022, Last downloaded: ClinicalTrials.gov processed this data on September 20, 2023, Last updated: September 20, 2023 | ||
520 | |a This registration includes concept elicitation, analysis and creation of complementary survey measures focused on edema/fluid overload of nephrotic syndrome. The measures to be developed include an Observer Reported Outcome (ObsRO) and Patient Reported Outcome (PRO). The ObsRO and PRO substudies are Institutional Review Board (IRB) approved at release.The researcher's goal is to produce core outcome sets of patient-rated and observer reported Fluid Overload (edema) measures that can be applied across the fluid overload severity continuum, fit to help drug development in this area. | ||
650 | 2 | |a Kidney Diseases | |
650 | 2 | |a Nephrotic Syndrome | |
650 | 2 | |a Nephrosis | |
650 | 2 | |a Glomerulonephritis, Membranous | |
650 | 2 | |a Nephrosis, Lipoid | |
650 | 2 | |a Glomerulosclerosis, Focal Segmental | |
650 | 2 | |a Syndrome | |
650 | 2 | |a Edema | |
650 | 4 | |a Study Type: Observational | |
650 | 4 | |a Recruitment Status: Recruiting | |
650 | 4 | |a 610 | |
773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2023) vom: 13. Sept. |
773 | 1 | 8 | |g year:2023 |g day:13 |g month:09 |
856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT05505500 |z kostenfrei |3 Volltext |
912 | |a GBV_CTG | ||
951 | |a AR | ||
952 | |j 2023 |b 13 |c 09 |